Nu Skin Enterprises, Inc. ( NUS ) Nowojorska Giełda Papierów Wartościowych

Cena: 7.94 ( 2.65% )

Aktualizacja 06-26 21:45
Nowojorska Giełda Papierów Wartościowych
Branża: Household & Personal Products
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna

Notowania:

Informacje o spółce:
Sektor: Dobra konsumpcyjne – niecykliczne
Branża: Household & Personal Products
Zatrudnienie: 3 700
Giełda: Nowojorska Giełda Papierów Wartościowych
Ilość akcji w obrocie: 98%
Ilość akcji: 49 959 000
Debiut giełdowy: 1996-11-22
WWW: https://www.nuskin.com
CEO: Mr. Ryan S. Napierski
Adres: 75 West Center Street
Siedziba: 84601 Provo
ISIN: US67018T1051
Opis firmy:

NU Skin Enterprises, Inc. rozwija i rozpowszechnia produkty piękności i dobrego samopoczucia na całym świecie. Zapewnia systemy pielęgnacji skóry, w tym systemy AGELOC SPA, transformacja Ageloc Transformation Systems Skin Care Systems oraz Ageloc Lumispa Treatment i urządzenia do czyszczenia; oraz AGELOC BOOST, a także szereg innych produktów kosmetycznych i higieny osobistej. Firma oferuje również AGELOC Youth Nutritional Suplements, AGELOC TR90 Systemy zarządzania masy ciała i kształtowanie ciała, suplementy diety LifePak, suplementy AgeloC Meta żywieniowe oraz suplementy kolagenu pielęgnacyjnego Beauty Focus+, a także inne produkty ciężarowe. Ponadto bierze udział w badaniach i rozwoju produktów produktów do pielęgnacji skóry i suplementów diety. Ponadto firma prowadzi sklepy detaliczne i centra usług w Chinach kontynentalnych. Sprzedaje swoje produkty pod markami NU Skin, Pharmanex i Ageloc. Firma promuje i sprzedaje swoje produkty bezpośrednio, a także za pośrednictwem dystrybutorów i strony internetowej. NU Skin Enterprises, Inc. został założony w 1984 roku i ma siedzibę w Provo, Utah.

Wskaźniki finansowe
Kapitalizacja (USD) 392 092 155
Aktywa: 1 582 895 000
Cena: 7.94
Wskaźnik Altman Z-Score: 3.0
Stabilny (niskie ryzyko bankructwa)
Dywidenda: 0
P/E: -9.9
Ilość akcji w obrocie: 98%
Średni wolumen: 602 641
Ilość akcji 49 413 000
Wskaźniki finansowe
Przychody TTM 1 775 172 000
Zobowiązania: 876 020 000
Przedział 52 tyg.: 5.32 - 11.64
Piotroski F-Score: 5
Umiarkowany (średnia jakość finansowa)
EPS: -0.8
P/E branży: 21.1
Beta: 1.13
Raport okresowy: 2025-08-06
WWW: https://www.nuskin.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Chayce David Clark Executive Vice President & General Counsel 896 471 1983
Mr. Steven J. Lund Co-Founder & Executive Chairman of the Board 856 608 1953
Mr. James D. Thomas Executive Vice President, Chief Accounting Officer & Chief Financial Officer 689 297 1979
Mr. Steve Keith Hatchett Executive Vice President & Chief Product Officer 633 262 1972
Mr. Blake M. Roney Founder 621 693 1959
Mr. Ryan S. Napierski President, Chief Executive Officer & Director 1 792 505 1974
Dr. Joseph Y. Chang Ph.D. Executive Vice President & Chief Scientific Officer 1 123 057 1953
Ms. Sandra N. Tillotson Founder 1 055 983 1957
Mr. Joe Sueper Senior Vice President & Chief Technology Officer 0 0
Mr. Mark L. Adams Chief Information Officer 0 1952
Wiadomości dla Nu Skin Enterprises, Inc.
Tytuł Treść Źródło Aktualizacja Link
Nu Skin Enterprises, Inc. (NUS) Q1 2025 Earnings Call Transcript Nu Skin Enterprises, Inc. (NYSE:NUS ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants B.G. Hunt - Investor Relations Ryan Napierski - President & Chief Executive Officer James Thomas - Chief Financial Officer Operator Good day, and thank you for standing by. seekingalpha.com 2025-05-08 22:10:50 Czytaj oryginał (ang.)
Nu Skin Enterprises Reports First Quarter Revenue at High End of Guidance PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced first quarter revenue at the high end of its guidance range. Executive Summary Q1 2025 vs. Prior-year Quarter Revenue $364.5 million; (12.7)% (3.0)% FX impact or $(12.3) million Earnings Per Share (EPS) $2.14 or $0.23 excluding Mavely gain and other charges compared to $(0.01) or $0.09 excluding restructuring charges Customers 776,712; (11)% Paid Affiliates 131,518; (15)% Sales Leaders 31,036; (20)% “We are pleas. businesswire.com 2025-05-08 20:06:00 Czytaj oryginał (ang.)
Nu Skin Enterprises to Announce First Quarter 2025 Financial Results PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2025 results after the market closes on Thursday, May 8. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives. The webcast of the conference call, including the financial information presented, will be available on the investor. businesswire.com 2025-04-02 20:15:00 Czytaj oryginał (ang.)
5 Value Stocks With Exciting EV-to-EBITDA Ratios to Scoop Up We have screened value stocks OPFI, NUS, BJRI, MRC and KT based on the EV-to-EBITDA ratio, which gives the true picture of valuation and earnings potential. zacks.com 2025-03-18 09:15:20 Czytaj oryginał (ang.)
Top Beauty and Cosmetics Stocks in Focus Right Now Beauty and Cosmetics stocks like NUS, ULTA and SBH are thriving on innovation, digital engagement and strategic expansions. zacks.com 2025-02-26 11:20:59 Czytaj oryginał (ang.)
Don't Overlook These Top Dividend Stocks Under $20: KT, PAX, NUS Here are three top-rated Zacks stocks to consider under $20 with generous dividends. zacks.com 2025-02-25 16:55:24 Czytaj oryginał (ang.)
Is Nu Skin Enterprises (NUS) Outperforming Other Consumer Staples Stocks This Year? Here is how Nu Skin Enterprises (NUS) and Primo Brands (PRMB) have performed compared to their sector so far this year. zacks.com 2025-02-25 12:41:02 Czytaj oryginał (ang.)
5 High Earnings Yield Value Stocks to Buy Amid Market Volatility Volatility looms with sticky inflation, a slowing economy and Trump's trade policies. Buy high-earnings-yield stocks like NUS, HRMY, PAHC, DAN and NRG. zacks.com 2025-02-24 11:10:32 Czytaj oryginał (ang.)
Nu Skin Q4 Earnings Beat Estimates, Rhyz Revenues Increase Y/Y NUS Q4 results reflect lower revenues and higher earnings. The adjusted operating margin expands 130 bps y/y. zacks.com 2025-02-14 14:30:31 Czytaj oryginał (ang.)
Nu Skin Enterprises, Inc. (NUS) Q4 2024 Earnings Call Transcript Nu Skin Enterprises, Inc. (NYSE:NUS ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants B.G. Hunt - Head of Investor Relations Ryan Napierski - President & Chief Executive Officer James Thomas - Chief Financial Officer Conference Call Participants Sydney Wagner - Jefferies Christina Xue - D.A. seekingalpha.com 2025-02-14 02:36:02 Czytaj oryginał (ang.)
Nu Skin Enterprises (NUS) Q4 Earnings and Revenues Top Estimates Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.37 per share a year ago. zacks.com 2025-02-13 20:51:16 Czytaj oryginał (ang.)
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2024 Results Above Company Revenue Guidance PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2024 results above its latest revenue guidance. Executive Summary Q4 2024 vs. Prior-year Quarter Revenue $445.6 million; (8.8)% (4.1)% FX impact or $(20.1) million Rhyz revenue $83.1 million; 27.7% Earnings Per Share (EPS) $(0.73) or $0.38 excluding restructuring and other charges, compared to $0.15 or $0.37 excluding restructuring and other charges Customers 831,972; (15)% Paid Affil. businesswire.com 2025-02-13 18:06:00 Czytaj oryginał (ang.)
Nu Skin Gears Up for Q4 Earnings: What Surprise Awaits Investors? NUS' fourth-quarter 2024 results are likely to show the impacts of a tough operating backdrop and pressures within the direct selling industry. zacks.com 2025-02-10 14:05:22 Czytaj oryginał (ang.)
Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2025-02-06 13:05:54 Czytaj oryginał (ang.)
NUS Q4 Preliminary Revenues Reach Top End of Outlook, Stock Gains 9.8% Nu Skin's shares rally as the company stated that its preliminary revenues for Q4 came in at the upper end of its projected range. zacks.com 2025-01-14 16:56:08 Czytaj oryginał (ang.)
NUS Pilots First-in-Market Green Bond Reporting Tokenisation Initiative with Northern Trust and UOB SINGAPORE--(BUSINESS WIRE)-- #assetmanagement--The National University of Singapore (NUS), Northern Trust and UOB are proud to announce a groundbreaking collaboration to launch a first-in-market initiative aimed at tokenising green bond credentials. NUS is the first university in Singapore to implement blockchain technology for environmental, social, and governance (ESG) reporting. This initiative, a key milestone in green finance innovation, will leverage blockchain technology to enhance transparency, data integ. businesswire.com 2025-01-12 22:00:00 Czytaj oryginał (ang.)
Nu Skin: New Cash From Mavely's Sale Could Accelerate Inorganic Growth Nu Skin Enterprises sold its Mavely affiliate marketing platform for $250 million, achieving a 5x ROI since 2021, and plans to use the cash for debt reduction and innovation. The new cash influx could accelerate both inorganic and organic growth, with potential acquisitions enhancing revenue and free cash flow growth. NUS could benefit from potential tax reductions under the new U.S. administration, which may increase net income and stock demand. seekingalpha.com 2025-01-09 11:07:12 Czytaj oryginał (ang.)
What Does Nu Skin's Mavely Sale Mean for Its Long-Term Strategy? NUS' subsidiary has sold its Mavely affiliate marketing platform to Later for nearly $250 million, boosting innovation and resources. zacks.com 2025-01-06 14:46:29 Czytaj oryginał (ang.)
Nu Skin generated about five-times return on Mavely investment, says Jefferies After Nu Skin announced the sale of its marketing tech platform business, Mavely, to Summit Partners portfolio company Later, Jefferies noted that this transaction generated about a five-times return on company's investment in Mavely since the acquisition in 2021. Nu Skin's Q3 sales softness was offset by strength from the Rhyz business, with strength led by Mavely, noted the analyst, who also points out that the company will have a minority stake in the Later and Mavely combined businesses. Jefferies has a Hold rating and $7 price target on Nu Skin shares. https://thefly.com 2025-01-03 14:47:46 Czytaj oryginał (ang.)
Later Acquires Mavely for $250 Million, Unlocking New Opportunities for Marketers and Creators to Maximize their Return on Social BOSTON , Jan. 3, 2025 /PRNewswire/ -- Later, a leader in influencer marketing and social media management software and services, today announced its acquisition of Mavely, the leading Everyday Influencer Platform.® This acquisition accelerates Later's ability to deliver full-funnel impact and measurable ROI for marketers while enabling creators to maximize their earnings through social commerce. prnewswire.com 2025-01-03 08:00:00 Czytaj oryginał (ang.)